walker7782
$COYA
Recycled FUD from Oct 14. The "33%" claim is a patient misunderstanding 1:1:1 trial design (1/3 placebo, 1/3 low dose, 1/3 high dose). Coya publicly clarified weeks ago: the study remains strictly blinded and every patient received their assigned dose.
If 1/3 of participants suffered actual administration errors, the DSMB/FDA would’ve issued an immediate clinical hold and mandatory 8-K. Zero holds exist. Dredging up old Facebook comments at 52-week lows is classic noise.
10
